● Recruiting

A Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative Cancer

Condition: Breast Cancer · Sponsor: Atridia Pty Ltd.

PhasePhase 1

Planned participants15

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects with HR-Positive/HER2-Negative solid tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Kathy You · +61 02 9299 0433 · kathyyou@atridia.com

Ravi Patel · +61 452 363 506 · ravi.patel@atridia.com

Always discuss trial participation with your own doctor first.

Locations (3)

Lyell McEwin Hospital	Elizabeth Vale, South Australia, Australia	Recruiting
Ballarat Base Hospital	Ballarat, Victoria, Australia	Recruiting
Frankston Hospital	Frankston, Victoria, Australia	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07358377